Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Bulgaria accuses AstraZeneca of taking country's vaccine 'hope' away

Published 02/24/2021, 04:51 PM
Updated 02/24/2021, 06:45 PM
© Reuters. View of the AstraZeneca factory in Dunkirk

SOFIA (Reuters) - Bulgaria's health minister has accused AstraZeneca (NASDAQ:AZN) of failing to stick to its delivery schedule of COVID-19 vaccines to the country and demanded the immediate shipment of at least 52,800 doses that were postponed to March 1.

In a sharply worded letter, Health Minister Kostadin Angelov said AstraZeneca's failure to comply with the agreed deliveries was compromising the massive vaccination campaign the Balkan country launched late last week.

The health ministry spokesman confirmed the authenticity of the letter, which was published on the website of Bulgaria's NOVA television on Wednesday.

Dozens of Bulgarians have rushed to get a shot since Saturday, improving the country's record of inoculations, which was the worst in the European Union, but also quickly depleting the supplies of AstraZeneca doses.

AstraZeneca has told the EU it would cut vaccine deliveries to the 27-member bloc by 60% in the first quarter due to production problems. On Tuesday, an EU official told Reuters the company expected to deliver less than half of the doses it was contracted to supply to the bloc in the second quarter.

Under an EU scheme, Bulgaria ordered 4.5 million doses of AstraZeneca vaccine and arranged to receive them over 7 months, initially expecting to receive 450,000 doses in February, but has so far received only 117,000 shots.

Two deliveries for a total of 142,400 doses, confirmed on Feb. 15, were now being delayed to March 1 and reduced by about two-thirds, the letter said.

In the letter, Angelov demanded the immediate delivery of at least the 52,800 doses promised for March 1, saying that the Bulgarian government was ready to arrange air transport at its own expense as early as "tomorrow".

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"I emphasise that failure to stick to the announced delivery schedule by AstraZeneca compromises the vaccination campaign in Bulgaria," Angelov wrote.

"With the lack of vaccines that were supposed to be delivered by your company the message that your company sends to the Bulgarian people would sound like this: 'AstraZeneca has taken the hope out of your hands'," he said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.